This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Liver Disease
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The objective of this study is to evaluate the safety and effectiveness of Covidien's Hemostatic Patch to control bleeding during hepatic surgery. The performance of the Hemostatic Patch will be compared to Control as an adjunct to conventional hemostatic techniques.

Provided treatments

  • Device: Veriset Hemostatic Patch
  • Device: Fibrin Sealant (TachoSil®)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01324349. The sponsor of the trial is Medtronic - MITG and it is looking for 50 volunteers for the current phase.
Official trial title:
A Prospective, Multi-Center, Randomized, Single-Blind Study to Compare the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery